Lizza Hendriks

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Lizza Hendriks
May 21, 2025, 01:21 | Insight
Matthias Guckenberger: Multimodality treatment in synchronous oligometastatic NSCLC
Matthias Guckenberger, Chairman at UniversitätsSpital Zürich, shared a post on LinkedIn: "Hot off the press …
Apr 25, 2025, 18:44 | Insight
Giannis Mountzios on the ESMO Advanced Course on early-stage NSCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at HENRY DUNANT…
Apr 22, 2025, 13:19 | Blog
IASLC Board of Directors Elections 2025: Spotlight on Undesignated Seat Candidates
The International Association for the Study of Lung Cancer (IASLC) is currently conducting its 2025…
Feb 22, 2025, 14:43 | Blog
Giannis Mountzios: How active ADCs against oncogene-addicted NSCLC?
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Feb 19, 2025, 17:31 | Blog
Myriam Chalabi: Abstract submission now open for ESMO25
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher, Gastrointestinal Oncology at Antoni van Leeuwenhoek Netherlands…
Feb 18, 2025, 18:35 | Science
Giannis Mountzios: Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted NSCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Feb 18, 2025, 10:44 | Science
Stephanie Saw: Our review paper on ADCs in NSCLC with AGA is out
Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, reshared a post by Giannis…
Jan 27, 2025, 09:42 | Science
Giannis Mountzios: Are we treating our NSCLC patients with the optimal dose and duration of immunotherapy?
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Jan 25, 2025, 04:12 | Science
Jarushka Naidoo: De-Escalation Strategies With ICIs in NSCLC - Do We Already Have Enough Evidence?
Jarushka Naidoo, Thoracic oncologist at the Beaumont Hospital Dublin, shared a post on X about…
Dec 26, 2024, 15:22 | Insight
Ilias Houda: Our EORTC survey on resectability of stage III NSCLC
Ilias Houda, PhD Candidate in Thoracic Oncology at Amsterdam UMC, shared a post on LinkedIn…
Dec 2, 2024, 09:46 | Positive
Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As November came to a close, it's an ideal time to reflect on Lung Cancer…
Jul 18, 2024, 22:37 | Blog
ESMO Living Guideline on Oncogene-Addicted Metastatic NSCLC
European Society for Medical Oncology (ESMO) shared a post on LinkedIn: ''The new ESMO Living…
Jul 7, 2024, 15:44 | Blog
Francesco Cortiula: What evidences for the treatment of patients with stage III NSCLC excluded from trials?
Francesco Cortiula, Medical Oncologist at University Hospital of Udine, made the following post on X:…
May 24, 2024, 13:02 | Blog
Jose Carlos Benitez: Thrilled to have organized the EORTC LCG spring meeting at home Ayuntamiento de Málaga
Jose Carlos Benitez, Medical Oncologist at University Hospital Virgen de la Victoria, shared a post on…
Apr 5, 2024, 08:01 | Blog
Jordi Remon: In this ASCO Educational Book we summarize EGFR mutated lung cancer
Jordi Remon, Coordinator of the Cancer Medicine Department at CIOCC Barcelona – HM Nou Delfos,…
Mar 24, 2024, 23:26 | Blog
Jarushka Naidoo: ESMO Young Oncologists (YO) session on career navigation with ⁦Herbert Loong, Lizza Hendriks, Alfredo Addeo & I
Jarushka Naidoo shared a post on X: “ELCC24 ESMO Young Oncologists (YO) session on career…
Mar 15, 2024, 18:02 | Insight
Jarushka Naidoo: Join us All at Ireland Lung Cancer Conference On 12-13 April 2024
Jarushka Naidoo shared a post on X/Twitter: "All Ireland Lung Cancer Conference: Privileged to be…
All: 17 Posts: 1 - 100
Special Coverage